Please try another search
May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria. It operates through Pharmaceuticals and Beverage segments. The company offers pharmaceuticals, including anti-diabetic, anti-hypersensitive, anti-infective, anti-malaria, analgesic, cough and cold, and anxiolytics; and nature care products. It also provides beverage drinks, including bottled water under the Lily Water name; and hand and surface sanitizers under the Smartans name. In addition, the company engages in contract manufacturing of pharmaceutical products; and in healthcare and industrial packaging. May & Baker Nigeria Plc was incorporated in 1944 and is headquartered in Lagos, Nigeria.
Name | Age | Since | Title |
---|---|---|---|
Nnamdi N. Okafor | - | 2011 | CEO, MD & Executive Director |
Patrick Ajah | - | 2021 | CEO, MD & Executive Director |
Ayodeji S. Aboderin | - | - | Executive Director of Finance, CFO & Executive Director |
Daisy Ehanire Danjuma | 70 | 2019 | Non-Executive Chairman of the Board |
Edudie Abebe | - | 2003 | Non Executive Director |
Kolawole Olalekan Durojaiye | - | 2021 | Non-Executive Director |
Samuel Maduka Onyishi | 61 | 2019 | Non-Executive Director |
Rahila Ilegbodu | - | 2022 | Independent Non-Executive Director |
Michael Chineme Odumodu | - | 2023 | Independent Non Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review